MolNFT v1 · #9377 · protein
A novel dimer configuration revealed by the crystal structure at 2.4 ångströms resolution of human interleukin- 5
1HUL · Interleukin-5: “A novel dimer configuration revealed by the crystal structure at 2.4 ångströms resolution of human…”. X-ray diffraction, 1 pocket (best druggability 0.40). MolNFT v1 #9377 on GenesisL1: 3D structure, binding sites…
- PDB
- 1HUL
- Type
- protein
- Length
- 216 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Interleukin-5
- UniProt
- P05113
- Pockets
- 1 · best druggability 0.40
Structure
x-ray diffraction · 1 distinct chain · 66% helix, 7% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B | Interleukin-5 | protein | 108 | 66% helix, 7% strand | P05113 |
Pockets
1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 66 | 0.40 | 0.80 | 12 | empty |
Interfaces
1 interface between chains.
- A–B · 3424 Ų buried · 27 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 2 disulfide (disulfide).
Compared structures
- 1HUL · A novel dimer configuration revealed by the crystal structure at 2.4 ångströms resolution… · the same entry in another collection · chain B against B, TM-score 1.00
- P05113 · AlphaFold monomer V2.0 prediction for interleukin-5 (P05113) · a predicted model of the same protein · chain A against A, TM-score 0.96
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P05113
- Elsewhere: RCSB PDB 1HUL · PDBe 1HUL · UniProt P05113
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.